-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – OPL-015 in Pain
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - OPL-015 in Pain report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. OPL-015 in Pain Drug Details: OPL-015 is under development for the treatment of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – OPL-044 in Epilepsy
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - OPL-044 in Epilepsy report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. OPL-044 in Epilepsy Drug Details: OPL-044 is under development for the treatment of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – OPL-053 in Insomnia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - OPL-053 in Insomnia report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. OPL-053 in Insomnia Drug Details: OPL-053 is under development for the treatment of...
-
Sector Analysis
NewNigeria Upstream (Oil and Gas) Fiscal and Regulatory Guide, 2024
Nigeria Upstream (Oil and Gas) Fiscal and Regulatory Report Overview The upstream fiscal and regulatory outlook of Nigeria has undergone many changes. Nigeria has implemented different regimes for oil exploration and production such as the Production Sharing Agreement and Joint Venture and Concession Agreements. Moreover, the Petroleum Industry Act (PIA) restructures Nigeria's institutional framework governing the oil & gas sector. It establishes the Nigerian Upstream Regulatory Commission to regulate technical and commercial aspects of upstream operations and creates a separate...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – OPL-0401 in Proliferative Diabetic Retinopathy (PDR)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - OPL-0401 in Proliferative Diabetic Retinopathy (PDR) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. OPL-0401 in Proliferative Diabetic Retinopathy (PDR) Drug Details: OPL-0401 (SAR-407899) is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – OPL-0401 in Non-Proliferative Diabetic Retinopathy (NPDR)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - OPL-0401 in Non-Proliferative Diabetic Retinopathy (NPDR) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. OPL-0401 in Non-Proliferative Diabetic Retinopathy (NPDR) Drug Details: OPL-0401 (SAR-407899) is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Onureg in Waldenstrom Macroglobulinemia (Lymphoplasmacytic Lymphoma)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Onureg in Waldenstrom Macroglobulinemia (Lymphoplasmacytic Lymphoma) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Onureg in Waldenstrom Macroglobulinemia (Lymphoplasmacytic Lymphoma) Drug Details: Azacitidine (Onureg)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – OPL-009 in Hypertension
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. OPL-009 in Hypertension Drug Details: OPL-009 is under development for the treatment of hypertension....
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – OPL-0301 in Left Ventricular Dysfunction
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - OPL-0301 in Left Ventricular Dysfunction report and make more profitable business decisions. How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – OPL-0401 in Proliferative Diabetic Retinopathy (PDR)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. OPL-0401 in Proliferative Diabetic Retinopathy (PDR) Drug Details: OPL-0401 is under development for the treatment...